drugset / Trial / NCT01242579
A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and maraviroc gel and determine whether it is safe for daily use by healthy women in the United Kingdom
Timeline
- Start
- 2011-01
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Maraviroc | Other / unclassified | 0.1 % | Other |
| Subject | dapivirine | Small molecule | 0.05 % | Other |